4
Changes in Ownership
Compass Therapeutics, Inc. Filed Acc 0001171843-23-000846
Chief Operating Officer acquired 400,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bisker-Leib Vered Chief Operating Officer | 2023-02-08 | Grant or award | +400,000 | 1,484,914 | D | ||
| Derivatives | |||||||
| Bisker-Leib Vered Chief Operating Officer | 2023-02-08 | Grant or award · Stock Option (Right to Buy) | +600,000 | 600,000 | D | ||
Loading xslF345X03/ownership.xml…